Analysis of clinical distribution of streptococcus penumoniae and drug susceptibility test results
10.3969/j.issn.1671-8348.2017.07.015
- VernacularTitle:肺炎链球菌临床分布情况及药敏分析
- Author:
Yafei YIN
;
Meng SHI
;
Ling LU
;
Yong ZHOU
- Keywords:
streptococcus penumoniae infections;
drug monitoring;
drug susceptibility test
- From:
Chongqing Medicine
2017;46(7):913-915
- CountryChina
- Language:Chinese
-
Abstract:
Objective To understand the clinical distribution situation of streptococcus penumoniae (SP) and drug susceptibility test results to provide a basis for the clinical diagnosis,treatment and prevention of SP infection.Methods Totally 416 nonrepeat strains of SP were isolated during 2010 to 2015.Their identification and drug susceptibility test were performed by using the ATB Express bacterial identification system.The results were interpreted according to the standard of CLSI 2014 edition.Results In these 6 years,SP showed the isolation peak in spring and winter;the detection rate of respiratory tract specimens reached more than 90 ％;the young children and elderly people were predominant;SP maintained high sensitivity to penicillin,amoxicillin,etc.,the difference in the sensitivity rate and non-sensitivity rate had statistical significance(P＜0.05);but SP showed high level non-sensitivity to clindamycin,erythromycin,etc.,the difference in the sensitivity rate and non-sensitivity rate had no statistical significance (P＞0.05).Conclusion Although β-lactam antibiotics such as penicillin can still be used as the first choice of therapy,but PISP and PRSP show the increasing trend year by year;therefore the antibacterial drugs should be selected according to the drug susceptibility test results.
